Am. Redmond et al., BEHAVIORAL AND NEUROCHEMICAL EFFECTS OF DIZOCILPINE IN THE OLFACTORY BULBECTOMIZED RAT MODEL OF DEPRESSION, Pharmacology, biochemistry and behavior, 58(2), 1997, pp. 355-359
The activity of dizocilpine (MK-801; 0.1 and 0.3 mg/kg) administered o
nce daily intraperitoneally (IP) was assessed in the olfactory bulbect
omized rat model of depression. Olfactory bulbectomy (OB) is associate
d with a variety of behavioural abnormalities, such as hyperactivity i
n the ''open field'' test. Previous studies have shown that chronic ad
ministration of antidepressants can reverse this behavioural deficit.
In the present study, chronic treatment with 0.1 and 0.3 mg/kg of dizo
cilpine (IP) antagonized the lesion-induced hyperactivity in the ''ope
n field'' test. Acute treatment with dizocilpine was associated with a
n increase in locomotor activity in both sham-operated and OB rats, wi
th a greater response in the sham-operated group. Following chronic tr
eatment, this hyperactivity was found to be greater in the OB-treated
animals compared with the sham-treated animals. olfactory bulbectomy r
educed serotonin (5-HT), noradrenaline (NA), and dopamine (DA) concent
rations in the frontal cortex. Chronic dizocilpine administration did
not alter the 5-HT or NA response. In contrast, chronic administration
of dizocilpine to OB animals did attenuate the OB-related deficit in
DA. In the OB-operated control animals, there was an increase in DOPAC
levels. In conclusion, chronic dizocilpine administration displays an
tidepressant-like activity in the OB rat model of depression. However,
unlike conventional antidepressants, dizocilpine does not correct the
5-HT and NA neurotransmitter deficits occur in this model. (C) 1997 E
lsevier Science Inc.